Home Alzheimer’s Disease Case Study Shows Efficacy from Tocilizumab in Patient With COVID-19, Myeloma

Case Study Shows Efficacy from Tocilizumab in Patient With COVID-19, Myeloma

A case study of a patient in Wuhan, China, published in Blood Advances, found that tocilizumab (Actemra) may be an effective treatment for very ill patients with coronavirus disease 2019 (COVID-19) who also have multiple myeloma and other blood cancers.1

The report also indicated that patients with blood cancer may have atypical COVID-19 symptoms.

“Our patients with hematologic malignancies are immunosuppressed, which may put them at higher risk for novel coronavirus infection,” lead author Changcheng Zheng, MD, of the University of Science and Technology of China, said in a press release.2 “What are the characteristics of COVID-19 in patients with blood cancers? What is the optimal treatment approach? Everything is unknown, and that was the motivation for this study.”

The study subject, a 60-year-old man working in Wuhan, China who had been diagnosed with multiple myeloma…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

32 year old singer Tom Parker of The Wanted diagnosed with stage 4 glioblastoma

submitted by /u/Jexlan Continue Reading to the Source

Recent Comments